Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings

por Koshimichi, Hiroki, Ishibashi, Toru, Kawaguchi, Nao, Sato, Chisako, Kawasaki, Akira, Wajima, Toshihiro
Publicado 2018

Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study

por Yokoyama, Takato, Sakaguchi, Hiroki, Ishibashi, Toru, Shishido, Takao, Piedra, Pedro A., Sato, Chisako, Tsuchiya, Kenji, Uehara, Takeki
Publicado 2020

Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes

por Hirotsu, Nobuo, Sakaguchi, Hiroki, Sato, Chisako, Ishibashi, Toru, Baba, Keiko, Omoto, Shinya, Shishido, Takao, Tsuchiya, Kenji, Hayden, Frederick G, Uehara, Takeki, Watanabe, Akira
Publicado 2020